Xyzal (levocetirizine) is generally considered safe for seniors, but it comes with a few important caveats that don’t apply to younger adults. It’s a second-generation antihistamine, which puts it in a much safer category than older options like Benadryl. However, kidney function, other medications, and fall risk all factor into whether it’s the right choice for an older adult.
How Xyzal Compares to Older Antihistamines
The AGS Beers Criteria, a widely used list of medications that are potentially inappropriate for older adults, flags first-generation antihistamines like diphenhydramine (Benadryl) and chlorpheniramine (AllerChlor) as drugs to avoid in seniors. Xyzal is not on that list. The Beers Criteria names cetirizine (Zyrtec), fexofenadine (Allegra), and loratadine (Claritin) as safer alternatives for allergy relief, and levocetirizine is the active component of cetirizine, placing it in the same family.
A study of 48 healthy volunteers found that levocetirizine at its standard 5 mg dose had no measurable effect on memory, attention, or psychomotor performance after both single-dose and four-day use. Diphenhydramine, by contrast, significantly impaired divided attention and motor tracking even after a single dose. This distinction matters for seniors, who are more vulnerable to confusion and cognitive side effects from medications.
Kidney Function Is the Key Concern
The single biggest safety factor for seniors taking Xyzal is how well their kidneys work. Levocetirizine is cleared primarily through the kidneys, and since kidney function naturally declines with age, the drug can build up in the body more than it would in a younger person. The FDA label is explicit: dose selection for elderly patients should be cautious, typically starting at the low end, and monitoring kidney function is recommended.
The standard adult dose is 5 mg once daily, but the FDA provides a detailed adjustment schedule based on kidney function:
- Mild kidney impairment: 2.5 mg once daily
- Moderate impairment: 2.5 mg every other day
- Severe impairment: 2.5 mg twice per week
- End-stage kidney disease: Xyzal should not be used at all
Many older adults have some degree of reduced kidney function without knowing it, because it often produces no obvious symptoms. This is why a healthcare provider may want to check kidney function before settling on a dose. Taking the full 5 mg dose with compromised kidneys increases the likelihood of side effects like excessive drowsiness.
Drowsiness and Fall Risk
Xyzal causes far less sedation than first-generation antihistamines, but it’s not sedation-free. Somnolence (sleepiness) is the most commonly reported side effect in clinical trials. For seniors, even mild drowsiness carries real consequences. The CDC lists antihistamines as a class of medication linked to falls in older adults, noting their potential to cause dizziness, sedation, and blurred vision.
Clinical trials of Xyzal did not include enough patients aged 65 and older to determine whether they experience more drowsiness than younger adults. That gap in data means it’s worth paying close attention to how the medication affects alertness, particularly during the first few days of use or after a dose change.
Interactions With Common Senior Medications
One of the bigger practical risks for older adults is how Xyzal interacts with other medications that also cause drowsiness. Seniors are more likely to be taking multiple prescriptions, and several common drug classes can amplify Xyzal’s sedating effects:
- Benzodiazepines (prescribed for anxiety or sleep): combining them with Xyzal increases the risk of excessive sedation and should generally be avoided
- Opioid pain medications: the combination raises the risk of respiratory depression, profound sedation, and dangerous drops in blood pressure
- Muscle relaxants: can add to drowsiness and sedation
- Antipsychotic medications: also carry additive sedation risk
Alcohol intensifies these effects further. If you’re taking any of these medications, the interaction risk is something to discuss before adding Xyzal.
Urinary Retention and Dry Mouth
Although second-generation antihistamines have far fewer anticholinergic effects than their predecessors, Xyzal isn’t completely free of them. Urinary retention has been reported in post-marketing data, and the FDA label specifically warns that people with predisposing factors like an enlarged prostate (benign prostatic hyperplasia) should use levocetirizine with caution. If difficulty urinating develops while taking Xyzal, it should be stopped.
Dry mouth is another mild but notable side effect. In clinical trials, it occurred in about 2 to 3% of people taking Xyzal, compared to 1% on placebo. For seniors who already deal with dry mouth from other medications, this can compound the problem and contribute to dental issues or difficulty swallowing over time.
Practical Takeaways for Older Adults
Xyzal sits in a much safer category than Benadryl for seniors, and for many older adults with normal or mildly reduced kidney function, it’s a reasonable allergy medication. The main things to be aware of are straightforward: kidney function determines the right dose, other sedating medications can create compounding drowsiness, and even mild sedation increases fall risk in ways that matter more at 75 than at 35. Alternatives like fexofenadine (Allegra) may be worth considering for seniors who are especially sensitive to drowsiness, since it’s the least sedating of the second-generation antihistamines.